Actively Recruiting
Prospective Evaluation of Hemorrhoid Suture Mucopexy Combined With Laser Hemorrhoidoplasty for Symptomatic Hemorrhoidal Disease
Led by National and Kapodistrian University of Athens · Updated on 2026-02-11
100
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to evaluate the combined use of suture mucopexy, a stitch-based lift of prolapsed tissue, with Laser Hemorrhoidoplasty (LHP) in adults who have moderate-to-severe hemorrhoids (Grades II-IV). The study focuses on how long patients need pain medication after the procedure and whether they achieve complete symptom relief. Secondary goals include assessing quality of life, safety issues like bleeding or urinary retention, and rates of hemorrhoid recurrence or the need for re-operation. Participants will all receive the same combined procedure, which does not use Doppler guidance. The suture mucopexy lifts the prolapsed tissue and ties off blood vessels, while the laser treatment shrinks and scars the hemorrhoidal cushions. This minimally invasive approach is being observed without a comparison group. Follow-up visits are scheduled for 6 weeks, 6 months, and 12 months after surgery. Throughout the study, patients will be monitored for pain relief duration and symptom improvement soon after the procedure. Researchers will also evaluate hemorrhoid severity scores, complications, and any reoperations over the year following treatment. The total participation includes these follow-up visits and safety assessments to understand the procedure's effects over time.
CONDITIONS
Brief Title
Hemorrhoid Suture Mucopexy Combined With Laser Hemorrhoidoplasty
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults (over 18 years old).
- Symptomatic hemorrhoidal disease classified as Goligher Grades II, III, or IV.
- Patients with or without recurrent hemorrhoids after prior treatments such as rubber band ligation, infrared coagulation, or Milligan-Morgan surgery.
You will not qualify if you...
- Acutely thrombosed hemorrhoids.
- Presence of anal fistula or abscess requiring separate surgical management.
- Active inflammatory bowel disease (Crohn's disease or Ulcerative Colitis) involving the rectum.
- Previous stapled hemorrhoid surgery (Stapled Haemorrhoidopexy).
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo a minimally invasive procedure combining laser ablation and suture mucopexy to treat symptomatic hemorrhoidal disease.
1 procedure visit (in-person)
Duration - 12 months
Participants attend follow-up visits to monitor recovery, assess symptoms, and check for complications after the procedure.
3 visits at postoperative week 6, month 6, and month 12 (in-person)
Trial Site Locations
Total: 1 location
1
Ippokrateio Hospital
Athens, Greece
Actively Recruiting
Research Team
G
George Theodoropoulos
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here